SC 13G Filing

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

July 10, 2014

Accession Number

0000315066-14-003604

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →